ALSTON & BIRD LLP for BOEHRINGER & INGELHEIM PHARMACEUTICALS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Medicare Part D, policies surrounding biosimilar products, evidence-based medicine, transparency, False Claims Act, patent reform, drug pedigree.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL New | Health Pol. Adv'r, Sen Fin Comm; Leg. Ass't, Sen. J. Thune |
| RUDY MISSMAR New | — |
| MARK RAYDER New | Leg. Ass't, Rep. T. Latham; Leg. Ass't Rep. R. Frelinghuysen |
| COLIN ROSKEY New | Health Pol. Adv'r and Counsel, Sen. Fin. Comm. |
| THOMAS A SCULLY New | Administrator, Consultant, CMS; Counselor to the Dir., |
| MARILYN K YAGER New | Dep. Ass't to the Pres., White House Office of Public Liason |
Trade (domestic/foreign) TRD
Medicare Part D, policies surrounding biosimilar products, evidence-based medicine, transparency, False Claims Act, patent reform, drug pedigree.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL New | Health Pol. Adv'r, Sen Fin Comm; Leg. Ass't, Sen. J. Thune |
| RUDY MISSMAR New | — |
| MARK RAYDER New | Leg. Ass't, Rep. T. Latham; Leg. Ass't Rep. R. Frelinghuysen |
| COLIN ROSKEY New | Health Pol. Adv'r and Counsel, Sen. Fin. Comm. |
| THOMAS A SCULLY New | Administrator, Consultant, CMS; Counselor to the Dir., |
| MARILYN K YAGER New | Dep. Ass't to the Pres., White House Office of Public Liason |
Medicare/Medicaid MMM
Medicare Part D, policies surrounding biosimilar products, evidence-based medicine, transparency, False Claims Act, patent reform, drug pedigree.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL New | Health Pol. Adv'r, Sen Fin Comm; Leg. Ass't, Sen. J. Thune |
| RUDY MISSMAR New | — |
| MARK RAYDER New | Leg. Ass't, Rep. T. Latham; Leg. Ass't Rep. R. Frelinghuysen |
| COLIN ROSKEY New | Health Pol. Adv'r and Counsel, Sen. Fin. Comm. |
| THOMAS A SCULLY New | Administrator, Consultant, CMS; Counselor to the Dir., |
| MARILYN K YAGER New | Dep. Ass't to the Pres., White House Office of Public Liason |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| BOEHRINGER INGELHEIM GMBH | Germany | Germany | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.